Xtant Medical Holdings (XTNT) Net Income towards Common Stockholders (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Net Income towards Common Stockholders data on file, last reported at $57000.0 in Q4 2025.

• On a quarterly basis, Net Income towards Common Stockholders rose 101.8% year-over-year to $57000.0 in Q4 2025; TTM through Dec 2025 was $5.0 million, a 130.23% increase from a year earlier, with the FY2025 full-year figure at $5.0 million, up 130.23% from the prior year.
• Net Income towards Common Stockholders for Q4 2025 stood at $57000.0, down from $1.3 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for XTNT reached as high as $9.2 million in Q3 2023 and fell as low as -$6.2 million in Q4 2023.
• Historically, Net Income towards Common Stockholders has averaged -$1.3 million across 5 years, with a median of -$1.9 million in 2021.
• Across the five-year window, Net Income towards Common Stockholders sank 7531.03% in 2022 and jumped 492.31% in 2023, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$1.3 million in 2021, then sank by 74.62% to -$2.2 million in 2022, then tumbled by 180.85% to -$6.2 million in 2023, then surged by 48.98% to -$3.2 million in 2024, then jumped by 101.8% to $57000.0 in 2025.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $57000.0 in Q4 2025, $1.3 million in Q3 2025, and $3.6 million in Q2 2025.